Global Substance Use Disorder Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• November 2022: Indivior PLC and Opiant Pharmaceuticals entered into an agreement to strengthen and expand Indivior's position in the market for addiction treatment.

• November 2021: Sahyog Clinic, launched its new programs that include inpatient treatment of drug abuse and alcohol addiction, behavior and group therapy, substance abuse counseling, and detoxification from alcohol and drugs.

• November 2021: Pear Therapeutics, Inc. and Sandoz, a division of Novartis, announced the commercial launch of reset for patients with substance use disorders (SUD). The first and only prescription digital therapeutic with FDA authorization is reSET.

The global substance use disorder treatment market is witnessing significant growth, driven by several factors including the rising prevalence of substance abuse disorders, increasing awareness about mental health issues, and the growing availability of treatment options. Substance use disorder, which includes addiction to substances such as alcohol, opioids, and illicit drugs, has become a major public health concern worldwide. Governments and healthcare organizations are increasingly focusing on addressing this issue, which has led to the expansion of the treatment market.

One of the key segments within the substance use disorder treatment market is pharmaceuticals. Pharmaceutical interventions play a crucial role in managing substance abuse disorders by reducing cravings, alleviating withdrawal symptoms, and preventing relapse. Medications such as methadone, buprenorphine, naltrexone, and acamprosate are commonly used in the treatment of opioid, alcohol, and nicotine addiction. The demand for these medications is expected to rise as healthcare providers adopt a more comprehensive approach to managing substance use disorders.

Another important segment is behavioral therapies. Behavioral interventions, including cognitive-behavioral therapy (CBT), contingency management, and motivational interviewing, are effective in addressing the psychological aspects of addiction. These therapies help individuals modify their attitudes and behaviors related to substance abuse, develop coping strategies, and learn relapse prevention skills. As awareness about the efficacy of behavioral therapies grows, the demand for these interventions is expected to increase, driving market growth.

Pharmaceuticals and behavioral therapies, the substance use disorder treatment market also encompasses other modalities such as residential and outpatient programs, support groups, and digital therapeutics. Residential treatment programs provide intensive, round-the-clock care in a structured environment, while outpatient programs offer flexibility for individuals to attend therapy sessions while continuing with their daily activities. Support groups such as Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) provide peer support and encouragement for individuals in recovery. Digital therapeutics, including smartphone apps and online platforms, are emerging as convenient and accessible tools for delivering evidence-based interventions and monitoring progress remotely.

Geographically, North America dominates the global substance use disorder treatment market, owing to the high prevalence of substance abuse disorders and well-established healthcare infrastructure in the region. However, the market is also witnessing significant growth in regions such as Europe, Asia Pacific, and Latin America, driven by increasing awareness, changing social attitudes towards addiction, and government initiatives to expand access to treatment services.

In conclusion, the global substance use disorder treatment market is experiencing robust growth, fueled by factors such as rising prevalence of substance abuse disorders, expanding treatment options, and growing awareness about mental health issues. With a comprehensive approach that includes pharmaceuticals, behavioral therapies, and other modalities, healthcare providers are better equipped to address the complex needs of individuals struggling with addiction. As efforts to combat substance abuse intensify worldwide, the market for substance use disorder treatment is poised for further expansion in the coming years.

Global Substance Use Disorder Treatment Segment Analysis

In this report, the Global Substance Use Disorder Treatment Market has been segmented by Treatment, Type and Geography.

Global Substance Use Disorder Treatment Market, Segmentation by Geography

In this report, the Global Substance Use Disorder Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Substance Use Disorder Treatment Market Share (%), by Geographical Region, 2024

The global substance use disorder treatment market is projected to witness significant growth from 2020 to 2030 across various geographical regions including North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Substance use disorder, often referred to as addiction, encompasses a range of conditions characterized by an individual's compulsive drug-seeking behavior despite adverse consequences. With substance abuse posing a substantial burden on public health systems worldwide, there has been an increasing focus on developing effective treatments to address this issue.

North America is expected to dominate the substance use disorder treatment market owing to factors such as high prevalence rates of substance abuse, well-established healthcare infrastructure, and increasing awareness about addiction treatment options. The region is also witnessing significant investments in research and development activities aimed at discovering novel therapies and improving existing treatment modalities.

Europe is anticipated to hold a considerable share in the substance use disorder treatment market, driven by initiatives aimed at reducing the societal and economic burden of substance abuse. Government-funded programs, along with collaborations between healthcare organizations and research institutions, are contributing to the development of innovative treatment approaches and interventions.

In the Asia Pacific region, the substance use disorder treatment market is poised for robust growth due to changing socio-cultural norms, rapid urbanization, and increasing disposable income levels. Moreover, rising awareness about the importance of mental health and addiction treatment services is expected to drive market expansion in this region.

The Middle East and Africa region is witnessing a growing recognition of the need for effective substance use disorder treatment, fueled by rising incidences of substance abuse and alcoholism. Efforts to enhance healthcare infrastructure and expand access to addiction treatment services are likely to drive market growth in this region.

Latin America is expected to witness steady growth in the substance use disorder treatment market, supported by initiatives aimed at addressing the root causes of substance abuse and improving access to addiction treatment services. Government initiatives, coupled with collaborations between public and private sector stakeholders, are expected to bolster market growth in Latin America.

Overall, the substance use disorder treatment market is poised for significant expansion over the forecast period, driven by increasing awareness, evolving treatment approaches, and supportive government policies across various geographical regions. However, challenges such as stigma associated with addiction, limited access to treatment facilities in certain regions, and regulatory hurdles may hinder market growth to some extent.

This report provides an in depth analysis of various factors that impact the dynamics of Global Substance Use Disorder Treatment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers:

• Personalized Care
• Holistic Approach
• Patient-Centered Care

• Public Health Initiatives -Public health initiatives play a crucial role in addressing substance use disorder on a global scale. These initiatives are aimed at preventing substance abuse, promoting awareness, expanding access to treatment, and reducing the social and economic burden associated with addiction. Here are some key public health initiatives focused on the global substance use disorder treatment market:

  Public health agencies and organizations implement education and prevention programs to raise awareness about the risks of substance abuse and promote healthy behaviors. These programs often target schools, communities, and workplaces, providing information about the harmful effects of drugs and alcohol and teaching skills to resist peer pressure and make healthy choices.

  Public health initiatives advocate for evidence-based policies and regulations aimed at reducing substance abuse and its consequences. This includes advocating for stricter regulations on the marketing and sale of tobacco, alcohol, and other addictive substances, as well as policies to promote harm reduction strategies such as needle exchange programs and safe injection sites.

  Public health efforts focus on improving access to substance use disorder treatment services, including pharmacological interventions, behavioral therapies, and support programs. Initiatives may involve integrating substance use disorder treatment into primary care settings, expanding insurance coverage for addiction treatment services, and establishing comprehensive treatment networks to ensure continuity of care.

  Public health campaigns work to reduce the stigma associated with substance use disorder, which can prevent individuals from seeking help and accessing treatment. These campaigns aim to challenge negative stereotypes, promote empathy and understanding, and highlight the effectiveness of treatment and recovery.

  Public health agencies collect data on substance abuse trends, treatment utilization, and outcomes to inform policy development, resource allocation, and program planning. Surveillance systems monitor indicators such as drug overdose deaths, emergency department visits, and substance use prevalence rates to identify emerging trends and prioritize interventions.

  Public health initiatives on substance use disorder treatment often involve collaboration between governments, international organizations, non-governmental organizations (NGOs), and other stakeholders. These collaborations facilitate the exchange of best practices, capacity building, and resource sharing to address substance abuse on a global scale.

  These and other public health initiatives, countries can work towards reducing the burden of substance use disorder, improving treatment outcomes, and promoting overall public health and well-being.

Restraints:

• Workforce Shortages
• Co-occurring Disorders
• Limited Evidence Base

• Cultural and Linguistic Barriers -In the global substance use disorder treatment market, cultural and linguistic barriers present significant challenges that impact the delivery and effectiveness of treatment interventions. Cultural diversity plays a crucial role in shaping individuals' attitudes, beliefs, and behaviors towards substance use and treatment-seeking. Likewise, linguistic diversity adds another layer of complexity, affecting communication between patients and healthcare providers.

  Cultural barriers encompass various factors such as societal norms, religious beliefs, and cultural practices surrounding substance use and mental health. Stigma associated with addiction may prevent individuals from seeking treatment due to fear of judgment or social ostracism within their communities. Moreover, cultural differences in the perception of mental health and addiction may influence help-seeking behaviors and treatment preferences.

  Linguistic barriers pose challenges in accessing and understanding treatment information, communicating symptoms, and expressing emotional experiences effectively. Limited proficiency in the language spoken by healthcare providers may hinder individuals' ability to convey their needs accurately and understand treatment recommendations. This can lead to miscommunication, misunderstandings, and suboptimal treatment outcomes.

  Cultural and linguistic barriers requires a multifaceted approach that recognizes and respects diversity while ensuring equitable access to culturally and linguistically appropriate care. This involves integrating cultural competence training into healthcare practices to enhance providers' understanding of diverse cultural backgrounds and their impact on treatment-seeking behaviors. Additionally, employing interpreters and utilizing translated materials can facilitate effective communication and improve patient-provider interactions.

  Tailoring treatment approaches to align with cultural values and beliefs, such as incorporating traditional healing practices or involving family members in the treatment process, can enhance engagement and promote positive treatment outcomes. Moreover, fostering collaboration with community organizations and religious institutions can help reduce stigma, increase awareness, and facilitate access to treatment within culturally diverse populations.

  Cultural and linguistic barriers, the global substance use disorder treatment market can strive towards providing inclusive and accessible care that meets the diverse needs of individuals struggling with addiction worldwide.

Opportunities:

• Holistic Wellness Programs
• Collaborative Care Models
• Workforce Development

• Integration with Primary Care -The integration of substance use disorder (SUD) treatment with primary care is increasingly recognized as a crucial component of comprehensive healthcare delivery. By incorporating SUD treatment into primary care settings, healthcare providers can address addiction issues more effectively and holistically, improving patient outcomes and reducing healthcare disparities. This integration allows for early identification of substance use problems, timely intervention, and ongoing support within the familiar environment of primary care clinics.

  Primary care providers play a pivotal role in the early detection and management of substance use disorders due to their frequent interactions with patients and their ability to establish long-term relationships. By integrating SUD screening, brief interventions, and referral to treatment (SBIRT) protocols into routine primary care visits, providers can identify at-risk individuals and initiate appropriate interventions before addiction progresses to severe stages.

  Integrating SUD treatment with primary care facilitates a collaborative approach to patient care. Primary care teams can work alongside addiction specialists, mental health professionals, and social workers to develop personalized treatment plans that address the complex needs of individuals with substance use disorders. This multidisciplinary approach ensures that patients receive comprehensive care that encompasses medical, behavioral, and social aspects of addiction.

  Integrating SUD treatment with primary care helps reduce stigma associated with seeking help for substance use disorders. By normalizing discussions about addiction and providing non-judgmental support within the primary care setting, individuals may feel more comfortable disclosing their struggles with substance use and seeking appropriate treatment.

  Overall, the integration of SUD treatment with primary care holds great promise for improving access to evidence-based interventions, reducing healthcare costs, and enhancing the overall well-being of individuals affected by addiction. As healthcare systems continue to prioritize the integration of behavioral health services into primary care, the global substance use disorder treatment market is expected to witness further expansion and innovation in this area.

Key players in Global Substance Use Disorder Treatment Market include.

• Teva Pharmaceutical Industries Ltd
• Alkermes plc.
• Reckitt Benckiser Pharmaceuticals Inc.
• GlaxoSmithKline plc.
• Pfizer, Inc.
• Cipla Limited
• Intas Biopharmaceuticals
• Indivior PLC and Opiant Pharmaceuticals
• Sahyog Clinic,
• Pear Therapeutics, Inc. and Sandoz,

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis